BSE filing, NSE: NALINLEA. Summary written from the filing by ALFA Finder's alert engine.
Nalin Lease Finance Ltd: key numbers
- Share price
- ₹37.78
- Market cap
- ₹24.78 Cr
- Revenue (annual)
- ₹6.83 Cr
- Net profit (annual)
- ₹3.18 Cr
- P/E (TTM)
- 6.6×Sector 19.7×
- Promoter holding
- 74.87%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nalin Lease Finance Ltd
All →Nalin Lease Finance Q2 FY27 Results: Net Profit ₹1.1 Cr, Up 37.5% YoY
Nalin Lease Finance Ltd reported revenue from operations of ₹2.4 Cr (+33.3% YoY) and net profit of ₹1.1 Cr (+37.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.1 Cr · +37.5% YoY
Nalin Lease Finance Other Announcement
Nalin Lease Finance Limited filed the Regulation 74(5) certificate issued by its RTA, MUFG Intime India Pvt. Ltd., for the quarter ended September 30, 2026.
Nalin Lease Finance Annual General Meeting
Nalin Lease Finance Limited held its 35th Annual General Meeting on September 24, 2026. Shareholders approved the adoption of audited financial statements and the re-appointment of Director Dilipkumar Gandhi.
Nalin Lease Finance Annual General Meeting
Nalin Lease Finance Ltd will hold its 35th Annual General Meeting on September 24, 2026. The register of members will remain closed from September 18 to September 24.
Nalin Lease Finance Promoter Selling
Promoter Dilipkumar Nalinkant Gandhi sold 66,000 shares of Nalin Lease Finance Limited in an open market transaction. This reduces his stake by 1.0064%.
Nalin Lease Finance Promoter Buying
Promoter group entity Nplus Consultants Pvt Ltd acquired 66,000 shares (1.01% stake) of Nalin Lease Finance Limited through open market transactions. This increases the promoter's holding to 5.12%.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.